ARADIGM CORP (ARDM)

0.21
0.01 5.00
OTC
Prev Close 0.20
Open 0.23
Day Low/High 0.21 / 0.23
52 Wk Low/High 0.07 / 2.33
Volume 4.95K
Exchange OTC
Shares Outstanding 15.28B
Market Cap 7.03M
Div & Yield N.A. (N.A)

Latest News

Aradigm Announces Submission Of Responses To EMA Day 120 Questions And Meeting With FDA

Aradigm Announces Submission Of Responses To EMA Day 120 Questions And Meeting With FDA

Aradigm Corporation (OTCQB: ARDM) ("Aradigm" or the "Company") submitted responses to the European Medicines Agency (EMA) Day 120 questions on 23 January 2019.

Aradigm Announces Detailed Third Party Evaluation Results For Apulmiq (FDA)/Linhaliq (EMA)

Aradigm Announces Detailed Third Party Evaluation Results For Apulmiq (FDA)/Linhaliq (EMA)

Aradigm Corporation (OTCQB: ARDM) ("Aradigm" or the "Company") today announced specific, detailed results of an independent third party evaluation (TPE) of the Phase 3 clinical trial results for Apulmiq.

Aradigm Announces Results Of Third Party Verification For Apulmiq (formerly Linhaliq)

Aradigm Announces Results Of Third Party Verification For Apulmiq (formerly Linhaliq)

Aradigm Corporation (Nasdaq: ARDM) ("Aradigm" or the "Company") today announced results of a third party evaluation (TPE) of the Phase 3 clinical trial results for Apulmiq.

Aradigm Announces Third Quarter 2018 Financial Results

Aradigm Announces Third Quarter 2018 Financial Results

Aradigm Corporation (NASDAQ: ARDM) (the "Company") today announced financial results for the third quarter and nine months ended September 30, 2018.

Aradigm Announces Second Quarter 2018 Financial Results

Aradigm Announces Second Quarter 2018 Financial Results

Aradigm Corporation (NASDAQ: ARDM) (the "Company") today announced financial results for the second quarter and six months ended June 30, 2018.

Aradigm Announces The Appointment Of Dr. Theresa Matkovits To The Board Of Directors

Aradigm Announces The Appointment Of Dr. Theresa Matkovits To The Board Of Directors

Aradigm Corporation (NASDAQ: ARDM) (the "Company") today announced the appointment of Dr.

Aradigm Announces First Quarter 2018 Financial Results

Aradigm Announces First Quarter 2018 Financial Results

Aradigm Corporation (NASDAQ: ARDM) (the "Company") today announced financial results for the first quarter and three months ended March 31, 2018.

Aradigm Announces The EMA Has Completed Its Validation Of The MAA Submission

Aradigm Announces The EMA Has Completed Its Validation Of The MAA Submission

Aradigm Corporation (NASDAQ: ARDM) (the "Company") today announced the completed formal validation by the European Medicines Agency (EMA) of the Marketing Authorisation Application (MAA) for Linhaliq for the treatment of...

Aradigm Announces Fourth Quarter 2017 And Full Year Financial Results

Aradigm Announces Fourth Quarter 2017 And Full Year Financial Results

Aradigm Corporation (NASDAQ: ARDM) (the "Company") today announced financial results for the fourth quarter and full year ended December 31, 2017.

ARADIGM INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Aradigm Corporation To Contact The Firm

ARADIGM INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Aradigm Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Aradigm Corporation ("Aradigm" or the "Company") (NASDAQ:ARDM) of the March 12, 2018 deadline to seek the role of lead plaintiff in a...

Aradigm Submits Marketing Authorisation Application (MAA) To EMA For EU Marketing Approval Of Linhaliq In Non-Cystic Fibrosis Bronchiectasis

Aradigm Submits Marketing Authorisation Application (MAA) To EMA For EU Marketing Approval Of Linhaliq In Non-Cystic Fibrosis Bronchiectasis

Aradigm Corporation (NASDAQ: ARDM) (the "Company") today announced it has submitted its Marketing Authorisation Application (MAA) to European Medicines Agency (EMA) for Linhaliq™ for the treatment of non-cystic...

FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Aradigm Corporation To Contact The Firm

FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Aradigm Corporation To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf...

ARADIGM INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Aradigm Corporation To Contact The Firm

ARADIGM INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Aradigm Corporation To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Aradigm Corporation ("Aradigm" or the "Company") (NASDAQ:ARDM) of the March 12, 2018 deadline to seek the role of lead plaintiff in a...

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Aradigm Corporation Of Class Action Lawsuit And Upcoming Deadline - ARDM

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Aradigm Corporation Of Class Action Lawsuit And Upcoming Deadline - ARDM

Pomerantz LLP announces that a class action lawsuit has been filed against Aradigm Corporation ("Aradigm" or the "Company") (NASDAQ: ARDM) and certain of its officers.

The Klein Law Firm Reminds Aradigm Corporation Shareholders Of A Class Action And A Lead Plaintiff Deadline Of March 12, 2018

The Klein Law Firm Reminds Aradigm Corporation Shareholders Of A Class Action And A Lead Plaintiff Deadline Of March 12, 2018

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Aradigm Corporation (NASDAQ: ARDM) who purchased shares between July 27, 2017 and January 8, 2018.

ARDM EQUITY ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Aradigm Corporation And A Lead Plaintiff Deadline Of March 12, 2018

ARDM EQUITY ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Aradigm Corporation And A Lead Plaintiff Deadline Of March 12, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors who purchased Aradigm Corporation ("Aradigm") (NASDAQ:ARDM)...

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Aradigm Corporation Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of March 12, 2018

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Aradigm Corporation Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of March 12, 2018

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Aradigm Corporation ("Aradigm") (NASDAQ:ARDM) between July 27,...

The Klein Law Firm Notifies Aradigm Corporation Shareholders Of A Class Action And A Lead Plaintiff Deadline Of March 12, 2018 (ARDM)

The Klein Law Firm Notifies Aradigm Corporation Shareholders Of A Class Action And A Lead Plaintiff Deadline Of March 12, 2018 (ARDM)

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Aradigm Corporation (NASDAQ:ARDM) who purchased shares between July 27, 2017 and January 8, 2018.

Aradigm Receives Complete Response Letter From The FDA For Linhaliq NDA

Aradigm Receives Complete Response Letter From The FDA For Linhaliq NDA

Aradigm Corporation (NASDAQ: ARDM) (the "Company") today announces that it received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for...

ARDM INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Aradigm Corporation And A Lead Plaintiff Deadline Of March 12, 2018

ARDM INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Aradigm Corporation And A Lead Plaintiff Deadline Of March 12, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors who purchased Aradigm Corporation ("Aradigm") (NASDAQ: ARDM)...

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Aradigm Corporation To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Aradigm Corporation To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Aradigm Corporation Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of March 12, 2018

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Aradigm Corporation Of Commencement Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of March 12, 2018

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Aradigm Corporation ("Aradigm") (NASDAQ: ARDM) between July 27,...

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Aradigm Corporation

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Aradigm Corporation

The Klein Law Firm announces the commencement of an investigation of Aradigm Corporation (NASDAQCM:ARDM) concerning possible violations of federal securities laws.

Aradigm Loss Notice: Rosen Law Firm Reminds Aradigm Corporation Investors Of Important Deadline In Class Action - ARDM

Aradigm Loss Notice: Rosen Law Firm Reminds Aradigm Corporation Investors Of Important Deadline In Class Action - ARDM

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aradigm Corporation (NASDAQ: ARDM) from July 27, 2017 through January 8, 2018, inclusive (the "Class Period") of the important March...

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Aradigm Corporation (ARDM)

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Aradigm Corporation (ARDM)

The Klein Law Firm announces the commencement of an investigation of Aradigm Corporation (NASDAQCM:ARDM) concerning possible violations of federal securities laws.

ARDM INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Aradigm Corporation

ARDM INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Aradigm Corporation

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Aradigm Corporation ("Aradigm" or the "Company") (NASDAQCM: ARDM) violated federal securities laws.

ARDM SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Aradigm Corporation

ARDM SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Aradigm Corporation

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Aradigm Corporation ("Aradigm" or the "Company") (NASDAQCM: ARDM) violated federal securities laws.

INVESTOR ALERT: Holzer & Holzer Announces Class Action Lawsuit Filed On Behalf Of Investors In Aradigm

INVESTOR ALERT: Holzer & Holzer Announces Class Action Lawsuit Filed On Behalf Of Investors In Aradigm

Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased Aradigm Corporation ("Aradigm" or the "Company") (NASDAQ: ARDM) securities between July 27, 2017 and January...

TheStreet Quant Rating: E+ (Sell)